Valganciclovir prophylaxis for cytomegalovirus disease in kidney and simultaneous pancreas-kidney transplant recipients.

被引：0
|
作者：
Ciancio, G
Burke, G
Suzart, K
Vaidya, A
Roth, D
Kupin, W
Mattiazzi, A
Miller, J
机构：
来源：
JOURNAL OF UROLOGY | 2002年 / 167卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：371 / 371
页数：1
相关论文
共 50 条
  • [21] Acyclovir prophylaxis of cytomegalovirus disease in kidney transplant recipients
    Vila, A
    Guirado, LL
    Balius, A
    Díaz, M
    Baró, E
    Olaya, M
    Andrade, M
    Agraz, I
    Solá, R
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (06) : 2335 - 2336
  • [22] Incremental Value of the Pancreas Allograft to the Survival of Simultaneous Pancreas-Kidney Transplant Recipients
    Salvalaggio, Paolo R.
    Dzebisashvili, Nino
    Pinsky, Brett
    Schnitzler, Mark A.
    Burroughs, Thomas E.
    Graff, Ralph
    Axelrod, David A.
    Brennan, Daniel C.
    Lentine, Krista L.
    DIABETES CARE, 2009, 32 (04) : 600 - 602
  • [23] Obesity is Not Associated with Worse Outcomes for Type 2 Diabetic Simultaneous Pancreas-Kidney (SPK) Transplant Recipients.
    Forbes, R.
    Niederhaus, S.
    Fox, A.
    Fridell, J.
    Abrams, P.
    Olaitan, O.
    Kandeel, F.
    Urban, R.
    Curry, M.
    Odorico, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 389 - 390
  • [24] Dual Versus Single Graft Failure Affects Retransplantation Rate in Simultaneous Pancreas-Kidney Transplant Recipients.
    Casey, M.
    Wen, X.
    Santos, A.
    Rehman, S.
    Bucci, C.
    Gregg, J.
    Andreoni, K.
    Segal, M.
    TRANSPLANTATION, 2014, 98 : 69 - 70
  • [25] Delayed Kidney Graft Function in Simultaneous Pancreas-Kidney Transplant Recipients is Associated with Pancreas Allograft Failure
    Parajuli, S.
    Muth, B.
    Astor, B. C.
    Redfield, R. R.
    Mandelbrot, D.
    Odorico, J.
    Djamali, A.
    Kaufman, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 1154 - 1155
  • [26] Dual Versus Single Graft Failure Affects Retransplantation Rate in Simultaneous Pancreas-Kidney Transplant Recipients.
    Casey, M.
    Wen, X.
    Santos, A.
    Rehman, S.
    Bucci, C.
    Gregg, J.
    Andreoni, K.
    Segal, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 69 - 70
  • [27] PREEMPTIVE THERAPY VERSUS UNIVERSAL PROPHYLAXIS WITH VALGANCICLOVIR IN MINIMIZING THE RISK OF CYTOMEGALOVIRUS DISEASE IN KIDNEY TRANSPLANT RECIPIENTS
    Khan, Muhammad
    TRANSPLANT INTERNATIONAL, 2019, 32 : 295 - 295
  • [28] Cytomegalovirus infection in simultaneous pancreas-kidney transplantation
    Malaise, J
    Ricart, MJ
    Moreno, A
    Crespo, M
    Fernández-Cruz, L
    Van Ophem, D
    Squifflet, JP
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (06) : 2848 - 2850
  • [29] PREEMPTIVE THERAPY VERSUS UNIVERSAL PROPHYLAXIS WITH VALGANCICLOVIR IN MINIMIZING THE RISK OF CYTOMEGALOVIRUS DISEASE IN KIDNEY TRANSPLANT RECIPIENTS
    Khan, Muhammad Tassaduq
    SWISS MEDICAL WEEKLY, 2019, : 19S - 19S
  • [30] The Cardinal Features of Recurrent Autoimmunity in Simultaneous Pancreas-Kidney Transplant Recipients
    Hirshberg, Boaz
    CURRENT DIABETES REPORTS, 2010, 10 (05) : 321 - 322
12345